MTNB Return on Tangible Equity | MATINAS BIOPHARMA HOLDINGS, INC.

MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Return on Tangible Equity

2026-06-30: Return Tang Equity 262.05%.
2026-03-31: Return Tang Equity 796.92%.
2025-12-31: Return Tang Equity -2170.48%.
2025-09-30: Return Tang Equity -800.62%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	262.05%
2026-03-31	796.92%
2025-12-31	-2170.48%
2025-09-30	-800.62%
2025-06-30	-590.34%
2025-03-31	-1047.83%
2024-12-31	-749.27%
2024-09-30	-184.95%
2024-06-30	-155.34%
2024-03-31	-227.87%
2023-12-31	-154.05%
2023-09-30	-113.12%
2023-06-30	-87.95%
2023-03-31	-72.62%
2022-12-31	-65.04%
2022-09-30	-70.22%
2022-06-30	-66.08%
2022-03-31	-56.09%
2021-12-31	-48.36%
2021-09-30	-42.53%
2021-06-30	-36.79%
2021-03-31	-35.94%
2020-12-31	-37.80%
2020-09-30	-33.95%
2020-06-30	-30.13%
2020-03-31	-25.08%
2019-12-31	-60.54%
2019-09-30	-45.87%
2019-06-30	-38.70%
2019-03-31	-36.28%
2018-12-31	-119.47%
2018-09-30	-236.86%
2018-06-30	-177.95%
2018-03-31	-370.13%
2017-12-31	-244.73%
2017-09-30	-163.09%
2017-06-30	-112.34%
2017-03-31	-67.90%
2016-12-31	-271.76%
2016-09-30	-176.58%
2016-06-30	591.92%
2016-03-31	6605.21%
2015-12-31	-531.58%
2015-09-30	-397.56%
2015-06-30	-251.51%
2015-03-31	-535.06%
2014-12-31	-458.78%
2014-09-30	-189.18%
2014-06-30	-121.14%
2014-03-31	-66.67%
2013-12-31	-35.45%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-2170.48%
2024-12-31	-749.27%
2023-12-31	-154.05%
2022-12-31	-65.04%
2021-12-31	-48.36%
2020-12-31	-37.80%
2019-12-31	-60.54%
2018-12-31	-119.47%
2017-12-31	-244.73%
2016-12-31	-271.76%
2015-12-31	-531.58%
2014-12-31	-458.78%
2013-12-31	-35.45%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Petros Pharmaceuticals, Inc. (PTPI)	United States	$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)	United States	$0.002B
GeoVax Labs, Inc. (GOVX)	United States	$0.003B	-0.45
BioXcel Therapeutics, Inc. (BTAI)	United States	$0.002B
Silo Pharma, Inc. (SILO)	United States	$0.003B	-1.57
JUPITER NEUROSCIENCES, INC. (JUNS)	United States	$0.002B	-0.02
Genprex, Inc. (GNPX)	United States	$0.003B	-0.02
Alaunos Therapeutics, Inc. (TCRT)	United States	$0.003B	-1.44
ORAGENICS INC (OGEN)	United States	$0.002B
Nexentis Technologies Inc. (NXTS)		$0.002B